- Home
- ETON vs ACP Comparison
ETON vs ACP Comparison
Compare ETON & ACP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- ACP
- Stock Information
- Founded
- ETON 2017
- ACP 2010
- Country
- ETON United States
- ACP United States
- Employees
- ETON N/A
- ACP N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- ACP Investment Managers
- Sector
- ETON Health Care
- ACP Finance
- Exchange
- ETON Nasdaq
- ACP Nasdaq
- Market Cap
- ETON 329.8M
- ACP 336.6M
- IPO Year
- ETON 2018
- ACP N/A
- Fundamental
- Price
- ETON $14.41
- ACP $6.09
- Analyst Decision
- ETON Strong Buy
- ACP
- Analyst Count
- ETON 3
- ACP 0
- Target Price
- ETON $18.67
- ACP N/A
- AVG Volume (30 Days)
- ETON 243.0K
- ACP 337.9K
- Earning Date
- ETON 03-13-2025
- ACP 01-01-0001
- Dividend Yield
- ETON N/A
- ACP 17.79%
- EPS Growth
- ETON N/A
- ACP N/A
- EPS
- ETON N/A
- ACP N/A
- Revenue
- ETON $34,677,000.00
- ACP N/A
- Revenue This Year
- ETON $22.25
- ACP N/A
- Revenue Next Year
- ETON $81.48
- ACP N/A
- P/E Ratio
- ETON N/A
- ACP N/A
- Revenue Growth
- ETON 5.64
- ACP N/A
- 52 Week Low
- ETON $3.03
- ACP $5.55
- 52 Week High
- ETON $15.00
- ACP $7.17
- Technical
- Relative Strength Index (RSI)
- ETON 62.22
- ACP 52.13
- Support Level
- ETON $13.09
- ACP $5.92
- Resistance Level
- ETON $14.35
- ACP $6.50
- Average True Range (ATR)
- ETON 1.13
- ACP 0.06
- MACD
- ETON 0.08
- ACP 0.03
- Stochastic Oscillator
- ETON 82.60
- ACP 70.37
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About ACP abrdn Income Credit Strategies Fund
abrdn Income Credit Strategies Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income with a secondary objective of capital appreciation. It predominantly invests in debt and loan instruments of issues that operate in a variety of industries and geographic regions.